Company Long-Term Loans and Borrowings: vistagen.com (VTGN)
Anticipation of large-scale Phase 3 trials for an innovative social anxiety spray is fueling speculative demand, while actual revenue has yet to materialize. Vistagen Therapeutics (VTGN) relies on the development of rapid-acting depression therapies, planning monetization through insurance companies and pharmacies, with the indicator standing at 0.00. This chart of share price quotes confirms the commitment of Vistagen Therapeutics (VTGN) to the principles of bioethics and environmental responsibility in neuropharmacology.
Summary analytical data breakdowns for Vistagen (VTGN)
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- book capitalization information:
- debt level and financial liquidity data:
Total Debt to Capital Coefficient Vistagen Therapeutics|VTGN - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient VistaGen Therapeutics, Inc.|VTGN - Company Total Debt|Debt to Book Capital Vistagen|VTGN - Company Long-Term Debts|Company Short-Term Debts Vistagen|Critical Liquidity vistagen.com
- earnings and market multiples details:
Fundamental company valuation:Vistagen Therapeutics VTGN
Long-term debts represent a set of obligations with a maturity horizon of more than one year, reflecting the organization's long-term financing strategy and leverage level. Analyzing the value of a company's long-term debt allows for an assessment of capital stability, which is critical for Vistagen Therapeutics (VTGN) when financing clinical trials for sprays by retaining highly qualified neurobiologists through a system of stock option rewards.
Who Vistagen Therapeutics competes with
Company Long-Term Debts biogen.com BIIB|NBIX - Company Long-Term Debt|Company Long-Term Loans and Borrowings RGC (Regencell Bioscience Ltd)|Axsome Therapeutics Inc (AXSM) - Company Long-Term Debt|Long-Term Debt ACADIA Corp (ACAD)|Company Long-Term Liabilities XENE|Company Long-Term Debt VKTX|Company Long-Term Debts SUPN|Long-Term Debt Volume Catalyst Pharma|Company Long-Term Debt Denali Therapeutics Inc DNLI|Long-Term Debt Volume Harmony Corp (HRMY)|BHVN: Company Long-Term Liabilities|amylyx.com - Amount of Long-Term Liabilities|TRVI: Company Long-Term Debts|Praxis Precision Medicines Inc (PRAX) - Company Long-Term Debts|AVXL (Anavex Corp) - Company Long-Term Debts|CBLL - Long-Term Indebtedness|Company Long-Term Debts PRTA|ALEC - Long-Term Debt|Company Long-Term Debt Annexon ANNX|OMER: Company Long-Term Indebtedness|NGNE: Company Long-Term Liabilities|Company Long-Term Loans and Borrowings ACIU (AC Immune Inc)|VYGR (Voyager Therapeutics) - Company Long-Term Liabilities|NMRA: Amount of Long-Term Liabilities|SCLX (Scilex) - Company Long-Term Debts|TVGN: Company Long-Term Loans and Borrowings|Company Long-Term Debts ACOG|CGTX - Long-Term Debt|Company Long-Term Debt Inhibikase Therapeutics IKT|Company Long-Term Loans and Borrowings SAVA|Assertio Therapeutics - Company Long-Term Debts|COYA - Company Long-Term Debts|ovidrx.com (OVID) - Company Long-Term Debt|Long-Term Liabilities ABOS (Acumen Pharmaceuticals, Inc)|CRVO (CervoMed Inc.) - Company Long-Term Debts|Long-Term Debt Alterity Therapeutics Ltd ATHE|Company Long-Term Liabilities CLNN (Clene Inc.)|Company Long-Term Debts pepgen.com (PEPG)|Jupiter Neurosciences Inc - Company Long-Term Liabilities|Amount of Long-Term Liabilities RLMD (Relmada Corp)|Annovis Bio, Inc. - Company Long-Term Debts|Long-Term Debt Volume Grace Therapeutics, Inc. GRCE|AIFF: Company Long-Term Debts|Company Long-Term Liabilities Klotho Neurosciences|Company Long-Term Debt NeuroSense Therapeutics Ltd|Reviva Pharmaceuticals, Inc. (RVPH) - Long-Term Debt Volume|Company Long-Term Liabilities MTVA (MetaVia Inc)|Company Long-Term Debt NRXS (neuraxis.com)|Helius Medical Technologies - Company Long-Term Liabilities|Amount of Long-Term Liabilities PASG (Passage Bio Inc.)|Neuphoria - Company Long-Term Debts|Long-Term Indebtedness Minerva (NERV)|Athira Pharma, Inc. (ATHA) - Company Long-Term Debt|Company Long-Term Indebtedness ADXN|Company Long-Term Debt Alzamend Neuro Inc.|Company Long-Term Indebtedness CYCN (Cyclerion)|Company Long-Term Debts PTIX|KTTA - Long-Term Debt|Cortigent - Company Long-Term Liabilities|Company Long-Term Debts avenuetx.com ATXI|BCLI - Company Long-Term Debt|Company Long-Term Loans and Borrowings CARA (Cara Therapeutics Inc.)|Chromocell Therapeutics Corporation (CHRO) - Company Long-Term Debt|Long-Term Debt Eliem Therapeutics Inc. (ELYM)|Company Long-Term Liabilities ITCI|Company Long-Term Debt LBPH|Company Long-Term Debts MRNS|Long-Term Debt Volume NKGen Biotech Inc|Company Long-Term Debt NeuroBo NRBO|Long-Term Debt Volume Sage Therapeutics Inc (SAGE)|SNPX: Company Long-Term Liabilities|trevena.com - Amount of Long-Term Liabilities|VIGL: Company Long-Term Debts|Anew Medical Inc. (WENA) - Company Long-Term Debts|CERE (Cerevel) - Company Long-Term Debts